Delivery Order SPE2DB20D3505-SPE2DB26FYBYE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,400.47 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pens on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical product will be performed at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $22,033.26 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pens, with an ultimate completion date of July 25, 2025. This competitive award uses firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The pharmaceutical product will be performed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite...
- The Defense Logistics Agency awarded a $30,395.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pens on October 29, 2025. This non-set-aside contract, with a completion date of October 30, 2025, represents a pharmaceutical supply delivery to support federal medical procurement needs. The award leverages AmerisourceBergen's extensive role as a critical vendor within the DLA's Medical Supply Chain, where the company serves military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $12,941.16 to supply Dupixent 300 mg/2 ml pens on November 10, 2025, with completion expected by November 12, 2025. This firm fixed-price, non-set-aside delivery order represents a pharmaceutical supply requirement fulfilled through AmerisourceBergen's existing contractual relationship with the DLA. The order will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $15,036.39 delivery order to AmerisourceBergen Drug Corp for Dupixent 200 mg/1.14 ml pen injections, with performance in Conshohocken, Pennsylvania and completion targeted for September 2, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The award reflects the agency's ongoing procurement of specialty pharmaceutical products to support military...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $79,972.19 delivery order on November 12, 2025, for the supply of Dupixent 300 mg/2 mL pens. This non-competitive, firm fixed-price delivery order is set to be completed by November 13, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal military and...
- The Defense Logistics Agency awarded a $35,928.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on November 17, 2025, with an ultimate completion date of November 18, 2025. This non-set-aside contract was awarded competitively and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $23,888.85 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Dupixent 300 mg/2 ml pens (2 ml units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $110,776.11 for Dupixent 300 mg/2 mL pens on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded procurement supporting federal pharmaceutical supply needs. The contract will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $56,453.92 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pens on October 14, 2025, with completion targeted for October 15, 2025. This non-competitive, firm fixed-price delivery order represents a procurement of the specialty pharmaceutical product to support federal medical supply needs. The award was issued under a child contract mechanism, leveraging AmerisourceBergen's established relationship with DLA as a...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB26FYBYEDelivery Order
The Defense Logistics Agency awarded a $19,091.93 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pens on October 27, 2025, with an ultimate completion date of October 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The pharmaceutical product will be delivered to the vendor's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen's federal contract portfolio demonstrates extensive capability in supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support Defense Health Agency and military healthcare systems worldwide. The award reflects the vendor's continued role as a critical pharmaceutical distributor within the federal medical procurement supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.1k | 10/27/25 |